Research & Development
Sobi receives US FDA's complete response letter for NASP (nanoencapsulated sirolimus plus pegadricase)
29 June 2026 - Sobi (STO: SOBI), a Sweden-based biopharmaceutical company, announced on Friday that the company received a Complete Response Letter (CRL) from the US Food and Drug Administration (FDA)...
Anivive Lifesciences' Laverdia receives FDA approval to treat canine lymphoma
29 June 2026 - Anivive Lifesciences, a California-based pharmaceutical company, announced on Friday that the US Food and Drug Administration (FDA) Center for Veterinary Medicine has granted full appro...
Lupin's Enzalutamide Tablets receive for tentative US FDA approval
29 June 2026 - India-based global pharmaceutical company Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) announced on Friday that it has received tentative appr...
Vifor Fresenius and CSL announce European regulator recommends revoking TAVNEOS (avacopan) marketing authorisation
29 June 2026 - Vifor Fresenius Medical Care Renal Pharma (VFMCRP), a Swiss pharmaceutical company, and CSL, an Australian biopharmaceutical company, announced on Friday that the European Medicines Age...
bioMérieux files FDA application for rapid vaginitis diagnostic panel
26 June 2026 - French diagnostics company bioMérieux (Euronext Paris:BIM) announced on Friday that it has submitted a Dual 510(k)/CLIA Waiver application to the US Food and Drug Administration ...
FDA approves Merck's Keytruda combinations for first-line treatment of PD-L1-positive advanced triple-negative breast cancer
25 June 2026 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, announced on Thursday that the US Food and Drug Administration (FDA) has approved Keytru...